Lesson plan
Cipepofol
Cipepofol ( , ), also known as ciprofol or by its developmental code name HSK3486, sold under the brand name Cypsedo, is a general anesthetic related to propofol which is used for anesthesia and sedation. The drug is used by intravenous infusion. A short-acting and highly selective GABA A positive allosteric modulator, ciprofol is 4 to 6 times more potent than other phenol derivatives such as propofol or fospropofol. In May 2026, cipepofol was approved for medical use in the United States. Manufactured by Haisco Pharmaceutical Group, ciprofol underwent phase I and II trials in Australia and China.
Article summary
Cipepofol ( , ), also known as ciprofol or by its developmental code name HSK3486, sold under the brand name Cypsedo, is a general anesthetic related to propofol which is used for anesthesia and sedation. The drug is used by intravenous infusion. A short-acting and highly selective GABA A positive allosteric modulator, ciprofol is 4 to 6 times more potent than other phenol derivatives such as propofol or fospropofol. In May 2026, cipepofol was approved for medical use in the United States. Manufactured by Haisco Pharmaceutical Group, ciprofol underwent phase I and II trials in Australia and China.
Key claims
- publication date: 2022 — source: Wikipedia, revision 1376612237, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the publication date is "2022". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “Cipepofol”, revision 1376612237, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1376612237
Key claims and bibliography are generated from the same tracked claims and sources as the article page.